Divalproex Sodium Capsule, Delayed Release
Product Images NDC 46708-821

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 46708-821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex-125mg (Divalproex 125mg)

Label for Divalproex Sodium Delayed-Release Capsules, USP 125 mg with valproic acid activity. The package contains 100 sprinkle capsules, labeled for Rx only. Manufactured by Alembic Pharmaceuticals Limited, the label provides storage instructions, usage notes, and pharmacist dispensing guidance. Includes NDC 46708-821-31 and a barcode.*

FDA Label Image

Divalproex-figr1.jpg (Divalproex Figr1)

A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium and a placebo across a patient population. The x-axis shows the percentage of patients from 100 to 0, while the y-axis represents percent reduction in CPS rate from -100% to 100%, with annotations indicating improvement above 0% and worsening below 0%. Solid and dashed lines represent Divalproex Sodium and placebo, respectively.*

FDA Label Image

Divalproex-figr2.jpg (Divalproex Figr2)

A cumulative distribution plot showing the percentage reduction in CPS (clinical parameter) rate against the percentage of patients for two dosage groups of divalproex sodium delayed release capsules, 125 mg. The graph compares high dose (solid line) and low dose (dashed line) treatment effects, with vertical axis indicating percentage change from -100% to 100%, and horizontal axis showing patient percentage from 0 to 100, illustrating overall improvement or worsening trends.*

FDA Label Image

Divalproex-ifu-p2.jpg (Divalproex Ifu P2)

Divalproex sodium 125 mg delayed release capsule imprinted with 'D9' and an arrow symbol. The capsule is primarily white and appears in a close-up view held between fingers, showing the imprint clearly. The labeler Alembic Pharmaceuticals Limited is associated with this oral prescription drug product.*

FDA Label Image

Divalproex-ifu-p3.jpg (Divalproex Ifu P3)

An instructional illustration showing a capsule labeled "D9" being rotated as indicated by arrows. The capsule has the text "THIS E" partially visible, demonstrating how to handle or manipulate the capsule.*

FDA Label Image

Divalproex-ifu-p4.jpg (Divalproex Ifu P4)

An illustration showing a hand pouring small white beads from a capsule labeled "D9". This likely represents the delayed-release capsule dosage form of Divalproex sodium orally administered.*

FDA Label Image

Divalproex-ifu-p5.jpg (Divalproex Ifu P5)

FDA Label Image

Divalproex-structure.jpg (Divalproex Structure)

Chemical structure diagram showing the molecular arrangement of Divalproex sodium, the active ingredient in the medication. The diagram includes carbon, hydrogen, oxygen atoms, and a sodium ion (Na+), visually representing the compound's polymeric form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.